The Incidence of Arterial Thromboembolic Diseases in Inflammatory Bowel Disease: A Population-Based Study

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 1, 2008, Pages 41-45

  Bernstein, Charles N ^a   Wajda, Andre ^a   Blanchard, James F ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY THROMBOSIS; ARTICLE; CANADA; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; SMOKING; THROMBOEMBOLISM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE FACTORS; ARTERIAL OCCLUSIVE DISEASES; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; MALE; MANITOBA; MIDDLE AGED; MYOCARDIAL ISCHEMIA; REGISTRIES; SEX FACTORS; THROMBOEMBOLISM;

EID: 37449016439     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.09.016     Document Type: Article

References (33)

1. Bernstein C.N., Blanchard J.F., Houston D., et al. The incidence of venous thromboembolic disease among patients with IBD: a population-based study. Thromb Haemost 85 (2001) 430-434
2. Bernstein C.N., and Nabalamba A. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol 21 (2007) 507-511
3. Bernstein C.N., Sargent M., Vos H.L., et al. Mutations in clotting factors and inflammatory bowel disease. Am J Gastroenterol 102 (2007) 338-343
4. Jess T., Winther K.V., Munkholm P., et al. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 122 (2002) 1808-1814
5. Wolters F.L., Russel M.G., Sijbrandij J., et al., European Collaborative study group on Inflammatory Bowel Disease (EC-IBD). Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 55 (2006) 510-518
6. Masala G., Bagnoli S., Ceroti M., et al. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001. Gut 53 (2004) 1309-1313
7. Jess T., Loftus Jr. E.V., Harmsen W.S., et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 55 (2006) 1248-1254
8. Canavan C., Abrams K.R., and Mayberry J.F. Meta-analysis: mortality in Crohn's disease. Aliment Pharmacol Ther 25 (2007) 861-870
9. Bernstein C.N., Rawsthorne P., Cheang M., et al. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 101 (2006) 993-1002
10. Mahid S.S., Minor K.S., Soto R.E., et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 81 (2006) 1462-1471
11. Roos L.L., Mustard C.A., and Nicol J.P. Registries and administrative data: organization and accuracy. Med Care 31 (1993) 201-212
12. Bernstein C.N., Blanchard J.F., Rawsthorne P., et al. The epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 149 (1999) 916-924
13. Bernstein C.N., Blanchard J.F., Leslie W.D., et al. The incidence of fractures among patients with IBD: a population-based study. Ann Intern Med 133 (2000) 795-799
14. Bernstein C.N., Kliewer E., Wajda A., et al. The incidence of cancer among patients with IBD: a population-based study. Cancer 91 (2001) 854-862
15. Bernstein C.N., Wajda A., and Blanchard J.F. The clustering of other chronic inflammatory diseases in IBD: a population-based study. Gastroenterology 129 (2005) 827-836
16. Schneiderman J.H., Sharpe J.A., and Sutton D.M. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol 5 (1979) 331-337
17. Talbot R.W., Heppell J., Dozois R.R., et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61 (1986) 140-145
18. Halliday C.E., and Farthing M.J. Arterial thrombosis in Crohn's disease. Med J Aust 149 (1988) 559-560
19. Levy P.J., Tabares A.H., and Olin J.W. Lower extremity arterial occlusions in young patients with Crohn's colitis and premature atherosclerosis: report of six cases. Am J Gastroenterol 92 (1997) 494-497
20. Papa A., Danese S., Urgesi R., et al. Early atherosclerosis in patients with inflammatory bowel disease. Eur Rev Med Pharmacol Sci 10 (2006) 7-11
21. Spina L., Saibeni S., Battaglioli T., et al. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia. Am J Gastroenterol 100 (2005) 2036-2041
22. Koutroubakis I.E., Dilaveraki E., Vlachonikolis I.G., et al. Hyperhomocysteinemia in Greek patients with inflammatory bowel disease. Dig Dis Sci 45 (2000) 2347-2351
23. Oldenburg B., Fijnheer R., van der Griend R., et al. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?. Am J Gastroenterol 95 (2000) 2825-2830
24. Mahmood A., Needham J., Prosser J., et al. Prevalence of hyperhomocysteinemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 17 (2005) 739-744
25. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 158 (1998) 2101-2106
26. Eikelboom J.W., Lonn E., Genest Jr. J., et al. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131 (1999) 603-617
27. Younes-Mhenni S., Derex L., Berruyer M., et al. Large-artery stroke in a young patient with Crohn's disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia. Neurol Sci 221 (2004) 113-115
28. Saibeni S., Cattaneo M., Vecchi M., et al. Low vitamin B6 plasma levels, a risk factor for thrombosis in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 98 (2003) 112-117
29. Vagianos K., Bector S., and Bernstein C.N. The evidence for routine measurements of nutritional parameters and routine multivitamin supplementation in IBD regardless of disease activity. J Parenteral Enteral Nutr 31 (2007) 311-319
30. Collins C.E., Rampton D.S., Rogers J., et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 9 (1997) 1213-1217
31. Mevorach D., Goldberg Y., Gomori J.M., et al. Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn's disease. J Clin Gastroenterol 22 (1996) 141-143
32. Panteris V., Perdiou A., Tsirimpis V., et al. Acute coronary syndrome after infliximab therapy in a patient with Crohn's disease. World J Gastroenterol 12 (2006) 6235-6238
33. Abedin M., Scheurich D., Reimold S.C., et al. Acute coronary syndrome after infliximab infusion. Cardiol Rev 14 (2006) 50-52